Eiry Roberts, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 16,792 shares at $120.03 ($2.0M) on 2023-12-06, disclosed to the SEC on 2023-12-08.
Scheduled sale ($2.0M) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $120.03 | 8,396 | $1.0M | 50.0% |
| 2 | $120.03 | 8,396 | $1.0M | 50.0% |
| Total | $120.03 avg | 16,792 | $2.0M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-04 | $445K | — | Filing → |
| NBIX | SELL | 2024-02-15 | $296K | — | Filing → |
| NBIX | SELL | 2024-02-08 | $582K | — | Filing → |